Genomic Biomarkers to Improve Ulcerative Colitis Neoplasia Surveillance

No adequate means exist to identify the minority of ulcerative colitis (UC) patients destined to undergo neoplastic progression. Recognition of this subset would advance UC cancer surveillance by focusing the available management options onto the highest risk patients. Three different assays of geno...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bronner, Mary P., O'Sullivan, Jacintha N., Rabinovitch, Peter S., Crispin, David A., Chen, Lu, Emond, Mary J., Rubin, Cyrus E., Brentnall, Teresa A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Investigative Pathology 2008
Gaiak:
Regular Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2626395/
https://ncbi.nlm.nih.gov/pubmed/18988798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/ajpath.2008.080250
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak